Patient-reported outcomes for irritable bowel syndrome are associated with patients' severity ratings of gastrointestinal symptoms and psychological factors.
about
Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating.Predictors of response to a low-FODMAP diet in patients with functional gastrointestinal disorders and lactose or fructose intolerance.Functional urological disorders: a sensitized defence response in the bladder-gut-brain axis.Irritable bowel syndrome: an integrated explanatory model for clinical practice.Optimal management of constipation associated with irritable bowel syndromeMultidomain patient-reported outcomes of irritable bowel syndrome: exploring person-centered perspectives to better understand symptom severity scores.Which psychological factors exacerbate irritable bowel syndrome? Development of a comprehensive model.Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.The impact of physical complaints, social environment, and psychological functioning on IBS patients' health perceptions: looking beyond GI symptom severity.Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome.Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome.Linaclotide: promising IBS-C efficacy in an era of provisional study endpoints.Adverse events appear to unblind clinical trials in irritable bowel syndrome.Patient-reported outcome in colorectal health and disease.Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation
P2860
Q33463901-BF4980A4-9419-4A0A-BA3F-B17762924271Q33469889-0E49CA4E-711F-4021-A923-00622BB0361EQ34546729-A79D23AD-7F28-4715-A4AB-B44E40EE4AB5Q35565145-B6436905-3D07-4B7B-9598-590FD61734A8Q35586543-ED7BD022-8BE0-4DA3-B393-930302550800Q36573807-9ED54FBB-81AE-4F3F-A532-02A98C438A48Q36904014-7BDD18A9-5870-499B-A786-CF0343D6507AQ37189148-73EFC3A2-9E26-465B-8220-76AB1CD5B87BQ37289794-A209B671-6619-4E7A-991E-D408A0EAEA8EQ38029718-FB53FD60-EF1B-4F4E-B489-97C7F4C7754FQ38175457-569C0ACB-B6C1-448A-86D4-CF377177FB76Q42408269-E775EF3D-6072-4DFC-A9D8-D726A71DFF1DQ43439726-D6F03BFD-8AB6-43FD-9358-EDF390FCCF19Q48390955-C95460E8-90C2-4C55-9D3B-30E62C880866Q52558812-46C099B9-450F-485C-81B6-90EFF9C12B00Q57298241-2BF7CAEB-6C68-42CF-8115-83389E8465BC
P2860
Patient-reported outcomes for irritable bowel syndrome are associated with patients' severity ratings of gastrointestinal symptoms and psychological factors.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Patient-reported outcomes for ...... oms and psychological factors.
@ast
Patient-reported outcomes for ...... oms and psychological factors.
@en
type
label
Patient-reported outcomes for ...... oms and psychological factors.
@ast
Patient-reported outcomes for ...... oms and psychological factors.
@en
prefLabel
Patient-reported outcomes for ...... oms and psychological factors.
@ast
Patient-reported outcomes for ...... oms and psychological factors.
@en
P2093
P2860
P1476
Patient-reported outcomes for ...... oms and psychological factors.
@en
P2093
Amanda Smith
Cathrine Powell
Charles Baum
James Jaccard
Jeffrey Lackner
Leonard Katz
Rebecca Firth
Susan Krasner
Tatayna Raby
P2860
P304
957-964.e1
P356
10.1016/J.CGH.2011.06.014
P407
P577
2011-06-21T00:00:00Z